Database Query Results : Bevacizumab (brand Avastin), ,

BEV, Bevacizumab (brand Avastin): Click to Expand ⟱

Features:

Bevacizumab monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. Cancer, IV used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma.
Serious side effects, such as treatment-related mortality

Scientific Papers found: Click to Expand⟱

5360-

almon,

BEV,

Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series

Case Report,

NSCLC,

BBB↑, Dose↝, eff↓, OS↑,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Barriers & Transport ⓘ

BBB↑, 1,

Drug Metabolism & Resistance ⓘ

Dose↝, 1, eff↓, 1,

Functional Outcomes ⓘ

OS↑, 1,
Total Targets: 4

Pathway results for Effect on Normal Cells:

Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells